Publications
Detailed Information
혐색소성 신세포암(Chromophobe Renal Cell Carcinoma)에서 E-cadherin 단백의 발현 양상과 임상적 의의 : Expression of E-cadherin in Chromophobe Renal Cell Carcinoma and Its Prognostic Implication
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정은정 | - |
dc.contributor.author | 박혜성 | - |
dc.contributor.author | 민선영 | - |
dc.contributor.author | 배정모 | - |
dc.contributor.author | 문경철 | - |
dc.date.accessioned | 2012-05-31T01:05:42Z | - |
dc.date.available | 2012-05-31T01:05:42Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.citation | KOREAN JOURNAL OF PATHOLOGY; Vol.43 3; 238-243 | ko_KR |
dc.identifier.issn | 1738-1843 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76642 | - |
dc.description.abstract | Background: Chromophobe renal cell carcinoma is a category of renal cell carcinoma composed of histologically characteristic tumor cells. E-cadherin is an intercellular adhesion protein that has been correlated with tumor aggressiveness in many carcinomas, including clear cell renal cell carcinoma. However, the significance of an E-cadherin expression in chromophobe renal cell carcinoma is not known. Methods : We evaluated the E-cadherin expression status of 65 chromophobe renal cell carcinomas by performing immunohistochemical staining with the tissue microarray method. The percentage of positively stained tumor cells was evaluated and this was then classified into two categories: a low expression where 0 to 25% of the cells are positive, and a high expression where more than 25% of the cells are positive. Results : Among 65 cases, 11 cases (17%) showed a low expression, and 54 cases (83.0%) showed a high expression. The tumors with low expression were more likely to have a higher stage but this was not significant (p=0.056). On the survival analysis, a low E-cadherin expression was significantly associated with poor cancer-specific survival (p=0.005) and progression-free survival (p=0.003). Conclusions : The E-cadherin expression is a good prognostic marker for survival in patients with chromophobe renal cell carcinoma. | ko_KR |
dc.language.iso | ko | ko_KR |
dc.publisher | KOREAN SOCIETY PATHOLOGISTS | ko_KR |
dc.subject | Carcinoma | ko_KR |
dc.subject | E-cadherin | ko_KR |
dc.subject | Immunohistochemistry | ko_KR |
dc.title | 혐색소성 신세포암(Chromophobe Renal Cell Carcinoma)에서 E-cadherin 단백의 발현 양상과 임상적 의의 | ko_KR |
dc.title.alternative | Expression of E-cadherin in Chromophobe Renal Cell Carcinoma and Its Prognostic Implication | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | Jung, Eun-Jung | - |
dc.contributor.AlternativeAuthor | Park, Heae Sung | - |
dc.contributor.AlternativeAuthor | Min, Sun Young | - |
dc.contributor.AlternativeAuthor | Bae, Jeong Mo | - |
dc.contributor.AlternativeAuthor | Moon, Kyung Chul | - |
dc.identifier.doi | 10.4132/KoreanJPathol.2009.43.3.238 | - |
dc.citation.journaltitle | KOREAN JOURNAL OF PATHOLOGY | - |
dc.description.citedreference | YUAN W, 2008, PATHOL ONCOL RES | - |
dc.description.citedreference | Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035 | - |
dc.description.citedreference | Gwak GY, 2006, ONCOL REP, V15, P1117 | - |
dc.description.citedreference | Morell-Quadreny L, 2003, ANTICANCER RES, V23, P5005 | - |
dc.description.citedreference | Polascik TJ, 2002, UROLOGY, V60, P941 | - |
dc.description.citedreference | Amin MB, 2002, AM J SURG PATHOL, V26, P281 | - |
dc.description.citedreference | Rubin MA, 2001, HUM PATHOL, V32, P690 | - |
dc.description.citedreference | Markovic-Lipkovski J, 2001, TUMORI, V87, P173 | - |
dc.description.citedreference | Nagashima Y, 2000, PATHOL INT, V50, P872 | - |
dc.description.citedreference | Taki A, 1999, MODERN PATHOL, V12, P310 | - |
dc.description.citedreference | Heicappell R, 1999, ANTICANCER RES, V19, P1501 | - |
dc.description.citedreference | Fischer C, 1999, ANTICANCER RES, V19, P1513 | - |
dc.description.citedreference | Shimazui T, 1996, CANCER RES, V56, P3234 | - |
dc.description.citedreference | Tani T, 1995, INT J CANCER, V64, P407 | - |
dc.description.citedreference | KATAGIRI A, 1995, BRIT J CANCER, V71, P376 | - |
dc.description.citedreference | GIROLDI LA, 1994, INVAS METAST, V14, P71 | - |
dc.description.citedreference | FRIXEN UH, 1991, J CELL BIOL, V113, P173 | - |
dc.description.citedreference | STORKEL S, 1989, VIRCHOWS ARCH B, V56, P237 | - |
dc.description.citedreference | THOENES W, 1985, VIRCHOWS ARCH B, V48, P207 | - |
dc.description.citedreference | FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.